• Permits cost effective, whole-body metastatic surveys
  • Avoids biopsies for low grade tumors
  • Permits non-invasive differentiation of tumors from radiation necrosis
  • Permits early change in course of ineffective chemotherapy
  • Avoids unnecessary diagnostic and therapeutic surgeries.

    • Patient Management Outcomes showed that 

      • PET can change staging of CA in 43% of cases*

      • PET leads to major changes in management decisions in 39%*

      • PET increases diagnostic understanding in 59%**

      • PET influenced therapy choice in 36%**

       *(seltzer et al: abstract #408 snm 6/99- questionaire sent to 99 referring physicians)
      **(comens et al: abstract #427 snm 6/99-questionaire before & after 153 PET scans)